Christopher Robinson/LinkedIn
Jul 12, 2026, 15:56
Christopher Robinson: Nipocalimab Compared With IVIG and Prednisone in FNAIT-Risk Pregnancies
Christopher Robinson, Associate Professor Maternal Fetal Medicine at University of South Carolina, shared a post on LinkedIn:
“Design of a Phase 3, Multicenter, Randomized, Open-Label Study of Nipocalimab or IVIG and Prednisone in Pregnancies at Risk for Fetal and Neonatal Alloimmune Thrombocytopenia.”
Title: Design of a Phase 3, Multicenter, Randomized, Open-Label Study of Nipocalimab or IVIG and Prednisone in Pregnancies at Risk for Fetal and Neonatal Alloimmune Thrombocytopenia
Authors: James Bussel, Barbara Stegmann, Pamela Baker, Abbie Oey, Yanxin Jiang, Rebecca Zaha, Hillary Van Valkenburgh, Babajide Keshinro
Read the full article.
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Jul 13, 2026, 15:51Why Do We Need an Early Detection Test for Ovarian Cancer? – OCRF
-
Jul 13, 2026, 15:49Christopher Robinson: Internal Manual Aortic Compression for Temporary Control of Obstetric Pelvic Hemorrhage!
-
Jul 13, 2026, 15:46Can AI Reliably Predict IVF Outcomes? – Oasis Fertility
-
Jul 13, 2026, 15:44Marco Zaccaria: EndoLatam Brings Together Latin America’s Leaders in Endometriosis Care!
-
Jul 13, 2026, 15:21Jalid Sehouli: Please, Learn from the Past…and Fight for a Better Health Care System
-
Jul 13, 2026, 15:13This Week is Birth Trauma Awareness Week – Preeclampsia Foundation
-
Jul 13, 2026, 14:51World Population Day Reminds Us That Population Trends are About More Than Numbers – CFAS
-
Jul 13, 2026, 14:34Christopher Robinson: Predictive Value of Cervical Length Measured After 24 Weeks for Spontaneous Preterm Birth
-
Jul 13, 2026, 14:17Evelyn Ndinda: What are Purposes of the 20th and 24th Week Prenatal Visits?